GLUE
Monte Rosa Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Monte Rosa Therapeutics (GLUE) Stock: Buy, Sell, or Hold?
$10.50
-0.08 (-0.76%)
âŧ
5d:
+0.86%
30d:
-0.19%
90d:
-34.17%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect GLUE Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (87%)
Quality Score
51/100
Position
FAIR
30-Day Fair Range
$10.10 â $10.90
Position: FAIR
Forward P/E & Valuation
-5.0x
Next 12M consensus est.
Wall Street Target
$25.38
+141.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$9.88 / $11.20
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: GLUE is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When GLUE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GLUE is currently trading at $10.50, which is considered fair relative to its 30-day fair value range of $10.10 to $10.90.
Technical Outlook: Technically, GLUE is in a strong downtrend. Immediate support is located at $9.88, while resistance sits at $11.20.
Market Sentiment: GLUE scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.38 (+141.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GLUE is in a strong downtrend. Immediate support is located at $9.88, while resistance sits at $11.20.
Market Sentiment: GLUE scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.38 (+141.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$10.10 -
$10.90
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
Trading Range & Key Levels
30-Day Trading Range
$10.10 -
$10.90
Current vs Trading Range
FAIR
Support Level
$9.88
Resistance Level
$11.20
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding GLUE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 141.7% below Wall St target ($25.38)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.04
Wall Street Target
$25.38
(+141.7%)
Revenue Growth (YoY)
325.8%
Profit Margin
-186.2%
Share GLUE Analysis
Share this live GLUE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GLUE)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 19, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expresses optimism towards $GLUE stock, awaiting Q3 earnings announcement for clarity on certain regulatory matters.
Key Retail Themes:
earnings announcement
regulatory clarity
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:08 AM ET
Data refreshes hourly during market hours. Next update: 10:08 AM
Data refreshes hourly during market hours. Next update: 10:08 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLUE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
28 analysts |
$91 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 60 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 53 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 43 HOLD |
|
RAPP
Rapport Therapeutics, InâĻ |
STRONG BUY
16 analysts |
$64 | 58 HOLD |
Advanced GLUE Option Strategies
Professional options setups generated by AI based on today's GLUE price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GLUE Research Pages
